FL S1192

Health care practitioners who maintain electronic health records or work for facilities with such systems must electronically transmit prescriptions for medicinal drugs upon license renewal or by July 1, 2021, whichever is earlier, with exceptions for impracticality, research protocols, hospice/nursing home patients, and other specified circumstances.

Electronic prescribing software is prohibited from using economic incentives or other means to influence prescribing decisions or pharmacy selection at the point of care, including through advertising, instant messaging, or pop-up ads triggered by practitioner drug selections.

Electronic prescribing software may display payor formulary information only if nothing is designed to preclude or complicate patient selection of pharmacies or practitioner selection of medicinal drugs.

Refined definitions of "prescribing decision" (practitioner's or agent's decision to prescribe any medicinal drug) and "point of care" (time at which practitioner or agent prescribes any medicinal drug) in electronic prescribing provisions.

Department of Health authorized to adopt rules in consultation with Boards of Medicine, Osteopathic Medicine, Podiatric Medicine, Dentistry, Nursing, and Optometry to implement electronic prescribing requirements; act becomes effective January 1, 2020.